Bendectin: A Case of Mourning Sickness

Abstract

Get full access to this article

View all access options for this article.

References

Briggs

JAG

. Vomiting in pregnancy. Causes and management. Drugs 1975; 9: 299–306.

Milkovich

Van Den Berg

. An evaluation of the teratogenicity of certain antinauseant drugs. Am J Obstel Gynecol 1976; 125: 244–8.

Kullander

Kallen

. A prospective study of drugs and pregnancy. II. Anti-emetic drugs. Acta Obstet Gynecol Scand 1976; 55: 105–11.

Runner

. Symposium on 25 years of progress in mammalian genetics and cancer; inheritance of susceptibility to congenital deformity—embryonic instability. J Natl Cancer Inst 1954; 15: 637.

Runner

Miller

. Congenital deformity in the mouse as a consequence of fasting (abstract). Anal Rec 1956; 124: 437.

Rosenzweig

Blaustein

. Cleft palate in A/J mice resulting from restraint and deprivation of food and water. Teratology 1971; 3: 47–51.

Warkany

Petering

. Congenital malformations of the brain produced by short zinc deficiencies in rats. Am J Ment Defic 1973; 77: 645–53.

Hays

. Teratogenesis: a review of the basic principles with a discussion of selected agents: parts I and II. Drug Intell Clin Pharm 1981; 15: 444–58, 542–66.

McBride

. An etiological study of drug ingestion by women who give birth to babies with cleft palate. Aust NZ J Obstet Gynecol 1969; 9: 103–7.

10.

Midwinter

. Vomiting in pregnancy. Practitioner 1971; 206: 743–50.

11.

Check

. CDC study: no evidence for teratogenicitv of Bendectin (news). JAMA 1979; 242: 2518.

12.

AMA Department of Drugs. Drugs used in vertigo, motion sickness and vomiting. In: AMA drug evaluations. 4th ed. Chicago: American Medical Association, 1980: 408–29.

13.

Food and Drug Administration Advisory Committee. The Bendectin Peer Group Report. Washington, DC: U.S Department of Health, Education, and Welfare, April 1975: NDA 10–598.

14.

Henderson

IWD

. Congenital deformities associated with Bendectin. Can Med Assoc J 1977; 117: 721–2.

15.

Paterson

. Congenital deformities. Can Med Assoc J 1969; 101: 175–6.

16.

Paterson

. Congenital deformities associated with Bendectin. Can Med Assoc J 1977; 116: 1348.

17.

Rothman

Fyler

Goldblatt

Kreidberg

. Exogenous hormones and other drug exposures of children with congenital heart disease. Am J Epidemiol 1979; 109: 433–9.

18.

Harron

DWG

Griffiths

Shanks

. Debendox and congenital malformations in Northern Ireland. Br Med J 1980; 281: 1379–81.

19.

Korcoh

. The Bendectin debate. Can Med Assoc J 1980; 123: 922–8.

20.

Bronson

. Jury awards damages for birth defects alleged to Richardson-Merrell Inc. Wall Street Journal 1980; 60 (Mar 24): 19.

21.

Smithells

Sheppard

. Teratogenicity testing in humans: a method demonstrating safety of Bendectin. Teratology 1978; 17: 31–6.

22.

FDA Drug Bull 1981; 11: 1–2.

23.

Bendectin and pyloric stenosis. FDA Drug Bull 1983; 13: 14–15.

24.

Eskenazi

Bracken

. Bendectin (Debendox) as a risk factor for pyloric stenosis. Am J Obstet Gynecol 1982; 144: 919–24.